article SARS-CoV-2 variants: the role of sequencing and vaccine development Professor Martin Michaelis and Dr Mark Wass explain why new… 22 March 2021 | By Victoria Rees (Drug Target Review) Professor Martin Michaelis and Dr Mark Wass explain why new SARS-CoV-2 variants are emerging around the world and how vaccines will have to adapt in response.
news Protease inhibitor aprotinin shows promise against SARS-CoV-2 in cells Researchers have found that aprotinin, an approved drug for influenza… 5 November 2020 | By Victoria Rees (Drug Target Review) Researchers have found that aprotinin, an approved drug for influenza in Russia, combats SARS-CoV-2 in cells.